有效临床对话的力量：提高临床试验入组率。
Power of an effective clinical conversation: improving accrual onto clinical trials.
机构信息
National Cancer Institute, Bethesda, MD, USA.
出版信息
J Oncol Pract. 2012 Sep;8(5):282-6. doi: 10.1200/JOP.2011.000478. Epub 2012 Mar 27.
Abstract
The National Cancer Institute (NCI) is actively transforming clinical trials to revitalize the clinical trials system and improve patient accrual. For more than 30 years, NCI has provided information and communication resources about cancer clinical trials. The Institute supports a clinical trials Web site (www.cancer.gov/clinicaltrials) that receives nearly a half million page views a month. In addition, NCI's Cancer Information Service (800-4-CANCER, chat and e-mail) responds to 1,750 clinical trial inquiries every month. Although these numbers suggest that a high volume of clinical trial information is being exchanged between NCI, the public, and providers, most patients decide whether to participate in clinical trials during the patient-provider interaction.
摘要
美国国家癌症研究所（NCI）正在积极转变临床试验，以重振临床试验系统并提高患者入组率。30 多年来，NCI 一直提供有关癌症临床试验的信息和交流资源。该机构支持一个临床试验网站（www.cancer.gov/clinicaltrials），每月的页面浏览量接近 50 万次。此外，NCI 的癌症信息服务（800-4-CANCER，聊天和电子邮件）每月会收到 1750 次临床试验咨询。尽管这些数字表明 NCI、公众和医疗服务提供者之间正在进行大量的临床试验信息交流，但大多数患者是在医患互动期间决定是否参与临床试验的。
相似文献
1
Power of an effective clinical conversation: improving accrual onto clinical trials.
J Oncol Pract. 2012 Sep;8(5):282-6. doi: 10.1200/JOP.2011.000478. Epub 2012 Mar 27.
2
Analysis of Maryland cancer patient participation in National Cancer Institute-supported cancer treatment clinical trials.
J Health Care Poor Underserved. 2009 May;20(2 Suppl):120-34. doi: 10.1353/hpu.0.0162.
3
Analysis of Maryland cancer patient participation in national cancer institute-supported cancer treatment clinical trials.
J Clin Oncol. 2008 Jul 10;26(20):3380-6. doi: 10.1200/JCO.2007.14.6027.
4
The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations.
J Oncol Pract. 2013 Nov;9(6):267-76. doi: 10.1200/JOP.2013.001119. Epub 2013 Oct 15.
5
Organizational designs for achieving high treatment trial enrollment: a fuzzy-set analysis of the community clinical oncology program.
J Oncol Pract. 2012 Sep;8(5):287-91. doi: 10.1200/JOP.2011.000507. Epub 2012 May 1.
6
Feasibility of a Centralized Clinical Trials Coverage Analysis: A Joint Initiative of the American Society of Clinical Oncology and the National Cancer Institute.
J Oncol Pract. 2017 Jun;13(6):395-400. doi: 10.1200/JOP.2016.020313. Epub 2017 May 8.
7
Enrolling Older Adults Onto National Cancer Institute-Funded Clinical Trials in Community Oncology Clinics: Barriers and Solutions.
J Natl Cancer Inst Monogr. 2022 Dec 15;2022(60):117-124. doi: 10.1093/jncimonographs/lgac019.
8
Through the Lens of Patient Partners: Challenges in Accrual of Older Adults to NCI Clinical Trials.
J Natl Cancer Inst Monogr. 2022 Dec 15;2022(60):125-134. doi: 10.1093/jncimonographs/lgac022.
9
Effect of state-mandated insurance coverage on accrual to community cancer clinical trials.
Contemp Clin Trials. 2012 Sep;33(5):933-41. doi: 10.1016/j.cct.2012.06.001. Epub 2012 Jun 8.
10
The Effect of Positive SWOG Treatment Trials on Survival of Patients With Cancer in the US Population.
JAMA Oncol. 2017 Oct 1;3(10):1345-1351. doi: 10.1001/jamaoncol.2017.0762.
引用本文的文献
1
Disparities in cancer clinical trials information-seeking: Findings from the National Cancer Institute's Cancer Information Service.
Patient Educ Couns. 2024 Oct;127:108358. doi: 10.1016/j.pec.2024.108358. Epub 2024 Jun 24.
2
Refusal to participate in heart failure studies: do age and gender matter?
J Clin Nurs. 2016 Apr;25(7-8):983-91. doi: 10.1111/jocn.13135. Epub 2016 Feb 23.
3
Modeling and validating Bayesian accrual models on clinical data and simulations using adaptive priors.
Stat Med. 2015 Feb 20;34(4):613-29. doi: 10.1002/sim.6359. Epub 2014 Nov 6.
4
The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations.
J Oncol Pract. 2013 Nov;9(6):267-76. doi: 10.1200/JOP.2013.001119. Epub 2013 Oct 15.
本文引用的文献
1
AccrualNet: Addressing Low Accrual Via a Knowledge-Based, Community of Practice Platform.
J Oncol Pract. 2011 Nov;7(6):e32-9. doi: 10.1200/JOP.2011.000272. Epub 2011 Oct 21.
2
Clinicians' attitudes towards clinical trials of cancer therapy.
Br J Cancer. 2011 May 10;104(10):1535-43. doi: 10.1038/bjc.2011.119. Epub 2011 Apr 12.
3
Implementing clinical trials: a review of the attributes of exemplary clinical trial sites.
J Oncol Pract. 2010 Nov;6(6):328-30. doi: 10.1200/JOP.2010.000156.
4
Metaphor use and health literacy: a pilot study of strategies to explain randomization in cancer clinical trials.
J Health Commun. 2011 Jan;16(1):3-16. doi: 10.1080/10810730.2010.529494.
5
Lung cancer patients' decisions about clinical trials and the theory of planned behavior.
J Cancer Educ. 2011 Dec;26(4):641-8. doi: 10.1007/s13187-010-0169-8.
6
Enhancing decision making about participation in cancer clinical trials: development of a question prompt list.
Support Care Cancer. 2011 Aug;19(8):1227-38. doi: 10.1007/s00520-010-0942-6. Epub 2010 Jul 1.
7
Individuals' willingness to talk to their doctors about clinical trial enrollment.
J Health Commun. 2010 Mar;15(2):189-204. doi: 10.1080/10810730903528058.
8
Expanding the reach of a cancer palliative care curriculum through Web-based dissemination: a public-private collaboration.
J Cancer Educ. 2010 Sep;25(3):418-21. doi: 10.1007/s13187-010-0066-1.
9
A physician-directed intervention: teaching and measuring better informed consent.
Acad Med. 2009 Aug;84(8):1036-42. doi: 10.1097/ACM.0b013e3181acfbcd.
10
It's not just what you say, it's also how you say it: opening the 'black box' of informed consent appointments in randomised controlled trials.
Soc Sci Med. 2009 Jun;68(11):2018-28. doi: 10.1016/j.socscimed.2009.02.023. Epub 2009 Apr 11.
Zotero 插件